Physician profile
Gina M Mower
NPI 1104037514
$5,189.32
in general payments reported to CMS, 2019-2025
20 companies · $1,355 in 2025
The $1,355 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $272 · 2022: $823 · 2023: $1,153 · 2024: $1,586 · 2025: $1,355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,658 · Education: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,657.89 |
| Education | $435.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,760.82 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Abbvie INC. | $991.62 | 2021-2025 | |
| Pfizer INC. | $450.01 | 2022-2025 | |
| Genzyme Corporation | $427.83 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $230.94 | 2022-2025 | |
| Amgen INC. | $205.83 | 2021-2025 | Otezla, Otezla |
| Lilly USA, LLC | $185.06 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Incyte Corporation | $184.58 | 2022-2025 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $153.99 | 2024-2025 | Sotyktu |
| Ucb, INC. | $92.08 | 2022-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $87.01 | 2024-2025 | Dupixent, Libtayo |
| Dermavant Sciences, INC. | $86.85 | 2023-2024 | Vtama |
| Organogenesis INC. | $86.39 | 2022-2025 | Cygnus Dual, Novachor, Apligraf |
| Sanofi-Aventis U.S. LLC | $72.00 | 2025 | |
| Arcutis Biotherapeutics, INC. | $51.31 | 2024-2025 | Zoryve |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $41.84 | 2025 | Vtama |
| Sun Pharmaceutical Industries INC. | $27.43 | 2022 | |
| Leo Pharma INC. | $23.93 | 2023 | Adbry |
| Galderma Laboratories, L.P. | $16.27 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.53 | 2025 | Cabtreo, Jublia, Siliq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gina Mower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.